Enginuity Ep. 22: Entrepreneur/Alumnus Michael Triplett @ohiostateengineering
Enginuity Ep. 22: Entrepreneur/Alumnus Michael Triplett  @ohiostateengineering
Uploaded December 2024 | Updated November 2026, 1 day ago
Ohio State Engineering alumnus Michael Triplett is what you would call a serial biotech entrepreneur. Today, he is co-founder and board chair of Armatus Bio as well as co-founder and board member of Clarametyx Biosciences, a startup infectious disease company pursuing novel therapeutics and vaccines for the treatment and prevention of biofilm-related bacterial infections. Not so long ago, he co-founded and served as president and CEO of Myonexus Therapeutics, a clinical stage gene therapy company developing first-ever treatments for limb-girdle muscular dystrophies. Myonexus was acquired by Sarepta Therapeutics for more than $225 million in April 2019.  Excelling at the interfaces of business and innovation, Michael is passionate about translating world-class science and technology into transformative businesses, products and capabilities that enhance human health, American competitiveness, and economic opportunity. He focuses on life sciences technology ventures, innovation, technology-based economic development, and STEM education for students of all backgrounds.

http://engineering.osu.edu | twitter.com/osuengineering | instagram.com/osuengineering | facebook.com/osuengineering | threads.com/osuengineering
Enginuity Ep. 22: Entrepreneur/Alumnus Michael TriplettHappy HallOHween from Buckeye EngineeringNew B.S. in Engineering Technology - Lima CampusEngineering Real-World Solutions3-D printing adds new dimension to first-year engineeringWelcome Back, Buckeyes!Ohio States Engineering Education Innovation CenterNational Engineers Week 2023 - SaturdayBuckeye Engineer Isabela HyreBuckeye Engineer Didi KanuFirst-Year Engineering Design Showcase - AU2022buck-i-code 2018
Ohio State Engineering |

Enginuity Ep. 22: Entrepreneur/Alumnus Michael Triplett

SHARE TO X SHARE TO REDDIT SHARE TO FACEBOOK WALLPAPER